UCLA Health wins $750,000 grant to scale COVID-19 innovations and support health equity

On May 13, 2021, NEWS Medical Life Science reported that UCLA Health has received a $750,000 grant from the U.S. Economic Development Administration to scale healthcare innovations for COVID-19 response and recovery and to support health equity through BioFutures, a new LA County workforce development program for diversity in the biosciences.

The grant is part of the U.S. Department of Commerce's $29 million Scaling Pandemic Resilience Through Innovation and Technology (SPRINT) Challenge.

At $750,000, it is the largest-possible single award, with amounts ranging from $200,000 to $750,000. In its announcement, the EDA said the challenge "was launched to harness America's entrepreneurial potential to address the economic, health, and safety risks caused by the coronavirus pandemic through entrepreneurship and innovation."

Desert Horse-Grant, chief of innovation at UCLA Hospital System and co-executive director of UCLA Biodesign, said the grant will be used to create the Los Angeles Response to COVID (LA-R2C) Accelerator, a vehicle for the rapid assessment and acceleration of novel health technologies that support pandemic response and resilience.

To read the full article click HERE